InMode (INMD) Total Current Liabilities (2018 - 2026)

InMode (INMD) posted quarterly Total Current Liabilities of $77.4 million for Q1 2026, up 6.46% year-on-year from $72.7 million in Q1 2025, and up 9.34% on a QoQ basis from $70.7 million in Q4 2025.

InMode (INMD) Total Current Liabilities (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Total Current Liabilities for 9 consecutive years, with $77.4 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Current Liabilities rose 6.46% year-over-year to $77.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.4 million (up 6.46% YoY) and the FY2025 annual result came in at $70.7 million, up 1.28% from the prior year.
  • Total Current Liabilities grew to $77.4 million in Q1 2026 per INMD's latest filing, from $70.7 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for INMD reached as high as $97.7 million in Q2 2024 and fell as low as $49.8 million in Q1 2022.
  • A 5-year average of $68.1 million and a median of $66.5 million in 2025 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities soared 60.85% — and 2025, when it slumped 31.89%.
  • Year by year, Total Current Liabilities stood at $82.0 million in 2022, then fell by 21.8% to $64.1 million in 2023, then grew by 8.91% to $69.9 million in 2024, then climbed by 1.28% to $70.7 million in 2025, then advanced by 9.34% to $77.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $77.4 million, $70.7 million, and $68.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 18.38 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 6.32 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 11.66 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 4.57 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 1.41 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2.22 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 8.70 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.53 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 1.60 Bn
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 77.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 77.35 Mn
Dec 31, 2025 70.74 Mn
Sep 30, 2025 68.33 Mn
Jun 30, 2025 66.53 Mn
Mar 31, 2025 72.66 Mn
Dec 31, 2024 69.85 Mn
Sep 30, 2024 75.70 Mn
Jun 30, 2024 97.69 Mn
Mar 31, 2024 65.00 Mn
Dec 31, 2023 64.14 Mn
Sep 30, 2023 62.19 Mn
Jun 30, 2023 60.73 Mn
Mar 31, 2023 59.67 Mn
Dec 31, 2022 82.02 Mn
Sep 30, 2022 57.93 Mn
Jun 30, 2022 57.99 Mn
Mar 31, 2022 49.82 Mn
Dec 31, 2021 51.85 Mn
Sep 30, 2021 53.87 Mn
Jun 30, 2021 42.17 Mn